BNIVX | VIHAX | BNIVX / VIHAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 9 years | - |
Gain YTD | 1.163 | 1.127 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 29.5M | 8.22B | 0% |
Annual Yield % from dividends | 2.69 | 4.87 | 55% |
Returns for 1 year | -3.27 | 7.29 | -45% |
Returns for 3 years | -0.67 | 2.41 | -28% |
Returns for 5 years | N/A | 13.00 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SDGTX | 124.84 | 1.17 | +0.95% |
DWS Capital Growth Institutional | |||
FLRAX | 41.06 | 0.38 | +0.93% |
Nuveen Large Cap Select A | |||
LSMNX | 14.23 | 0.07 | +0.49% |
Loomis Sayles Small/Mid Cap Growth N | |||
WFMDX | 48.31 | 0.17 | +0.35% |
Allspring Special Mid Cap Value Admin | |||
FBDIX | 118.54 | -0.14 | -0.12% |
Franklin Biotechnology Discovery A |